scispace - formally typeset
R

Robert Tarran

Researcher at University of North Carolina at Chapel Hill

Publications -  157
Citations -  9861

Robert Tarran is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Cystic fibrosis & Cystic fibrosis transmembrane conductance regulator. The author has an hindex of 42, co-authored 136 publications receiving 8686 citations. Previous affiliations of Robert Tarran include Durham University.

Papers
More filters
Journal ArticleDOI

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

TL;DR: In CF patients with established lung disease, Pseudomonas aeruginosa was located within hypoxic mucopurulent masses in airway lumens, and in vitro studies revealed that CF-specific increases in epithelial O(2) consumption, linked to increased airway surface liquid (ASL) volume absorption and mucus stasis, generated steep hypoxic gradients within thickened mucus on CF epithelial surfaces prior to infection.
Journal ArticleDOI

Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease

TL;DR: In this paper, two hypotheses, "hypotonic [low salt]/defensin" and "isotonic volume transport/mucus clearance", attempt to link defects in cystic fibrosis transmembrane conductance regulator-mediated ion transport to CF airways disease.
Journal ArticleDOI

Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

TL;DR: In patients with cystic fibrosis, inhalation of hypertonic saline produced a sustained acceleration of mucus clearance and improved lung function, and in vitro data suggested that sustained hydration of airway surfaces was responsible for the sustained improvement in mucus clearing.
Journal ArticleDOI

Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis THE EFFECTS OF PHASIC SHEAR STRESS AND VIRAL INFECTIONS

TL;DR: How the normal coordination of opposing ion transport pathways to maintain PCL volume is disrupted in cystic fibrosis is demonstrated, the hitherto unknown role of phasic motion in regulating key aspects of normal and CF innate airways defense is discovered, and maneuvers directed at increasing motion-induced nucleotide release may be therapeutic in CF patients are demonstrated.
Journal ArticleDOI

What are the respiratory effects of e-cigarettes?

TL;DR: It is concluded that current knowledge of these effects is insufficient to determine whether the respiratory health effects of e-cigarette are less than those of combustible tobacco products.